Michael G. Baker

18.0k total citations · 1 hit paper
340 papers, 9.0k citations indexed

About

Michael G. Baker is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Michael G. Baker has authored 340 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Infectious Diseases, 110 papers in Public Health, Environmental and Occupational Health and 86 papers in Epidemiology. Recurrent topics in Michael G. Baker's work include COVID-19 epidemiological studies (60 papers), Streptococcal Infections and Treatments (54 papers) and Influenza Virus Research Studies (52 papers). Michael G. Baker is often cited by papers focused on COVID-19 epidemiological studies (60 papers), Streptococcal Infections and Treatments (54 papers) and Influenza Virus Research Studies (52 papers). Michael G. Baker collaborates with scholars based in New Zealand, Australia and United States. Michael G. Baker's co-authors include Philippa Howden‐Chapman, Nick Wilson, Kamalesh Venugopal, Simon Hales, Nick Wilson, Amanda Kvalsvig, Nigel French, Lucy Telfar-Barnard, Tony Blakely and Nevil Pierse and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Michael G. Baker

327 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009

2009 170 citations Michael G. Baker, Nick Wilson et al. profile →

Peers

Countries citing papers authored by Michael G. Baker

Since Specialization

Citations

This map shows the geographic impact of Michael G. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Baker more than expected).

Fields of papers citing papers by Michael G. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Baker. The network helps show where Michael G. Baker may publish in the future.

Co-authorship network of co-authors of Michael G. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Baker. A scholar is included among the top collaborators of Michael G. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Baker. Michael G. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Examining campylobacteriosis disease notification rates: Association with water supply characteristics 2025 ·Environmental Research ·(unknown), (unknown), Tim Chambers, (unknown), Michael G. Baker, Simon Hales	2
2	Practitioner perspectives on informing decisions in One Health sectors with predictive models 2025 ·Humanities and Social Sciences Communications ·Kim M. Pepin, Keith M. Carlisle, Richard B. Chipman, (unknown), Dean P. Anderson, Michael G. Baker, Jackie Benschop, Michael Bunce, Rachelle N. Binny, Nigel French, Suzie Greenhalgh, Dion O’Neale, S McDougall, Fraser Morgan, Petra Muellner, (unknown), Michael J. Plank, Daniel M. Tompkins, David T. S. Hayman	0
3	Multidrug-resistant Shigella flexneri outbreak affecting humans and non-human primates in New Mexico, USA 2025 ·Nature Communications ·Sarah Shrum Davis, (unknown), Karen Edge, (unknown), Jessica P. Houston, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael G. Baker, (unknown), Sarah Lathrop, Chad Smelser, Darrell L. Dinwiddie, Daryl Domman	2
4	Population and contact tracer uptake of New Zealand’s QR-code-based digital contact tracing app for COVID-19 2024 ·Epidemiology and Infection ·Tim Chambers, Andrew Anglemyer, Andrew Chen, (unknown), Michael G. Baker	2
5	Integrated Prevention and Control of Seasonal Respiratory Infections in Aotearoa New Zealand: next steps for transformative change 2022 ·Policy Quarterly ·Amanda Kvalsvig, Lucy Telfar-Barnard, Jennifer Summers, Michael G. Baker	4
6	Medical Treatment for Rheumatic Heart Disease: A Narrative Review 2022 ·Heart Lung and Circulation ·(unknown), Julie Bennett, William Leung, Rachel Webb, Susan Jack, Matire Harwood, Michael G. Baker, Mayanna Lund, Nigel Wilson	1
7	Increased Breadth of Group A Streptococcus Antibody Responses in Children With Acute Rheumatic Fever Compared to Precursor Pharyngitis and Skin Infections 2022 ·The Journal of Infectious Diseases ·Alana L. Whitcombe, Reuben McGregor, Julie Bennett, Jason Gurney, Deborah A. Williamson, Michael G. Baker, Nicole J. Moreland	15
8	The lived experience of hotel isolation and quarantine at the Aotearoa New Zealand border for COVID-19: A qualitative descriptive study 2022 ·International Journal of Disaster Risk Reduction ·Lesley Gray, Carol MacDonald, (unknown), (unknown), (unknown), (unknown), (unknown), Julia Becker, Amanda Kvalsvig, Michael G. Baker	6
9	Imported arboviral infections in New Zealand, 2001 to 2017: A risk factor for local transmission 2021 ·Travel Medicine and Infectious Disease ·(unknown), (unknown), Michael G. Baker, Simon Hales	3
10	How Aotearoa New Zealand rapidly revised its Covid‐19 response strategy: lessons for the next pandemic plan 2021 ·Journal of the Royal Society of New Zealand ·Amanda Kvalsvig, Michael G. Baker	22
11	Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand 2021 ·Epidemiology and Infection ·(unknown), (unknown), Alana L. Whitcombe, Reuben McGregor, (unknown), Campbell R. Sheen, James M. Dickson, Chris Bullen, Annie Chiang, Daniel Exeter, Janine Paynter, Michael G. Baker, Richard Charlewood, Nicole J. Moreland	7
12	Antibody responses to collagen peptides and streptococcal collagen-like 1 proteins in acute rheumatic fever patients 2021 ·Pathogens and Disease ·(unknown), Paul W. R. Harris, (unknown), Reuben McGregor, Renata Kowalczyk, (unknown), (unknown), Renwick C. J. Dobson, Michael G. Baker, Margaret A. Brimble, Sławomir Łukomski, Nicole J. Moreland	9
13	Expansion of a national Covid-19 alert level system to improve population health and uphold the values of Indigenous peoples 2021 ·The Lancet Regional Health - Western Pacific ·Amanda Kvalsvig, Nick Wilson, Cheryl Davies, (unknown), Virginia Signal, Michael G. Baker	5
14	Respiratory Syncytial Virus–Associated Hospitalizations Among Adults With Chronic Medical Conditions 2020 ·Clinical Infectious Diseases ·Namrata Prasad, Tiffany Walker, Ben Waite, Tim Wood, Adrian Trenholme, Michael G. Baker, Colin McArthur, Conroy Wong, Cameron Grant, Q. Sue Huang, E. Claire Newbern	60
15	Potential public health benefits from eradicating rats in New Zealand cities and a tentative research agenda 2017 ·Journal of the Royal Society of New Zealand ·Nick Wilson, (unknown), Paul Blaschke, Petra Muellner, Osman Mansoor, Michael G. Baker	8
16	Remembering the 1918 influenza pandemic: national survey of memorials and scope for enhancing educational value around pandemic preparedness. 2017 ·PubMed ·Nick Wilson, (unknown), (unknown), Michael G. Baker, (unknown), Christine M. Clement, George Thomson	1
17	Volume 35 Number 3 2014 ·Microbiology Australia ·John Tagg, Frank W. Austin, Terry Maguire, Sandy Smith, J. S. Mackenzie, Anne Kelso, Alan Hampson, Nick Wilson, Jennifer Summers, Michael G. Baker, Jonathan R. Iredell, Paul R. Young, John Whitehall, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
18	Prevalence and risk factors for Chlamydia trachomatis infection in female New Zealand university students. 2005 ·PubMed ·Michael G. Baker, (unknown), (unknown), Collette Bromhead, (unknown), (unknown), Anne McNicholas	10
19	Estimating the impact of the next influenza pandemic on population health and health sector capacity in New Zealand. 2004 ·PubMed ·Nick Wilson, Osman Mansoor, Michael G. Baker	12
20	A re-appraisal of the burden of infectious disease in New Zealand: aggregate estimates of morbidity and mortality. 2002 ·PubMed ·(unknown), Martin Tobias, Michael G. Baker	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact